HUP0104032A2 - Új rendszer transzgén kifejeződés szabályozására - Google Patents

Új rendszer transzgén kifejeződés szabályozására

Info

Publication number
HUP0104032A2
HUP0104032A2 HU0104032A HUP0104032A HUP0104032A2 HU P0104032 A2 HUP0104032 A2 HU P0104032A2 HU 0104032 A HU0104032 A HU 0104032A HU P0104032 A HUP0104032 A HU P0104032A HU P0104032 A2 HUP0104032 A2 HU P0104032A2
Authority
HU
Hungary
Prior art keywords
transgene expression
novel system
regulating transgene
regulating
novel
Prior art date
Application number
HU0104032A
Other languages
English (en)
Inventor
Olga Corti
Jacques Mallet
Original Assignee
Aventis Pharma S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9814080A external-priority patent/FR2786198B1/fr
Application filed by Aventis Pharma S.A. filed Critical Aventis Pharma S.A.
Publication of HUP0104032A2 publication Critical patent/HUP0104032A2/hu
Publication of HUP0104032A3 publication Critical patent/HUP0104032A3/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C12N15/861—Adenoviral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0071—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/635—Externally inducible repressor mediated regulation of gene expression, e.g. tetR inducible by tetracyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/022—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from an adenovirus
HU0104032A 1998-11-09 1999-11-09 Novel system for regulating transgene expression HUP0104032A3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9814080A FR2786198B1 (fr) 1998-11-09 1998-11-09 Nouveau systeme de regulation de l'expression d'un transgene
US12260099P 1999-03-03 1999-03-03
PCT/FR1999/002752 WO2000028062A1 (fr) 1998-11-09 1999-11-09 Nouveau systeme de regulation de l'expression d'un transgene

Publications (2)

Publication Number Publication Date
HUP0104032A2 true HUP0104032A2 (hu) 2002-02-28
HUP0104032A3 HUP0104032A3 (en) 2003-09-29

Family

ID=26234639

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0104032A HUP0104032A3 (en) 1998-11-09 1999-11-09 Novel system for regulating transgene expression

Country Status (11)

Country Link
EP (1) EP1129204B1 (hu)
JP (1) JP4516215B2 (hu)
KR (1) KR20020013476A (hu)
CN (1) CN1352694A (hu)
AT (1) ATE317020T1 (hu)
AU (1) AU1165400A (hu)
CA (1) CA2351015C (hu)
DE (1) DE69929718T2 (hu)
HU (1) HUP0104032A3 (hu)
IL (1) IL142761A0 (hu)
WO (1) WO2000028062A1 (hu)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6440741B2 (en) * 1999-03-15 2002-08-27 The Trustees Of Columbia University In The City Of New York Expression vector for consistent cellular expression of the tet on repressor in multiple cell types
EP1386968A4 (en) * 2001-04-09 2004-12-22 Mitsubishi Pharma Corp UNIT TO CONTROL AND USE GENE EXPRESSION
CN1453361A (zh) * 2003-05-30 2003-11-05 中国科学院上海生命科学研究院 一种抗癌靶向可调控基因－病毒的构建方法
BR112012010755A2 (pt) * 2009-11-05 2015-09-22 Proyecto Biomedicina Cima Sl constructo de gene que permite a expressão hepato-específica induzível de um polinucleotídeo de interesse em resposta a um agente indutor, vetor, genoma viral recombinante, vírion, método in vitro para a expressão de um polinucleotídeo de interesse em uma célula de origem hepática, composição farmacêutica e operador-promotor bi-direcional induzível adequado para a expressão hepato-específica induzível de dois polinucleotídeos de interesse por um agente indutor
CN102690338A (zh) * 2012-05-25 2012-09-26 中国农业大学 一种与四环素结合的蛋白TetR及其编码基因和应用
CN110358812B (zh) * 2019-06-25 2022-12-27 武汉生物工程学院 一种用于λ-Red重组系统基因敲除重组阳性克隆检测的引物及检测方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5650298A (en) * 1993-06-14 1997-07-22 Basf Aktiengesellschaft Tight control of gene expression in eucaryotic cells by tetracycline-responsive promoters
US5965440A (en) * 1995-12-07 1999-10-12 The General Hospital Corporation Controlled gene product delivery from a regulatable retroviral vector
WO1998037185A2 (en) * 1997-02-20 1998-08-27 The Board Of Regents Of The University Of Texas System Vectors for controlled gene expression

Also Published As

Publication number Publication date
EP1129204B1 (fr) 2006-02-01
JP2002529099A (ja) 2002-09-10
KR20020013476A (ko) 2002-02-20
ATE317020T1 (de) 2006-02-15
CA2351015A1 (fr) 2000-05-18
CN1352694A (zh) 2002-06-05
CA2351015C (fr) 2011-09-27
AU1165400A (en) 2000-05-29
IL142761A0 (en) 2002-03-10
DE69929718D1 (de) 2006-04-13
JP4516215B2 (ja) 2010-08-04
DE69929718T2 (de) 2006-11-09
WO2000028062A1 (fr) 2000-05-18
HUP0104032A3 (en) 2003-09-29
EP1129204A1 (fr) 2001-09-05

Similar Documents

Publication Publication Date Title
GB2329924B (en) Single control system for top-down-bottom-up shades
HUP0200558A3 (en) Expression system for factor viii
GB2375241B (en) Control system
GB9914828D0 (en) Process control system
GB9810726D0 (en) Control system
GB2335055B (en) Fuel control system
GB9710522D0 (en) Control system
GB2340723B (en) Load-activated animal control system
GB9725714D0 (en) Control system
HUP0104032A3 (en) Novel system for regulating transgene expression
GB9410145D0 (en) Jumps for horses
EP1017279A4 (en) METHOD FOR REGULATING THE TRKA EXPRESSION
GB9815658D0 (en) Radiocomminications system controller
GB9721929D0 (en) Novel control system
GB9621383D0 (en) Transgene expression
ZA965332B (en) Melosis regulating compounds
GB2342145B (en) Control system
GB9810743D0 (en) Transgene expression
GB2346227B (en) Stock control system
GB2336447B (en) Control system
GB9810742D0 (en) Transgene expression
GB9822028D0 (en) Control system
GB9827429D0 (en) Control system
PL324103A1 (en) Optically controlled feeder
GB9425846D0 (en) Means for animal control